慢性中性粒细胞白血病伴意义未明单克隆免疫球蛋白增高1例并文献复习

来源 :临床血液学杂志 | 被引量 : 0次 | 上传用户:fencer_2
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的:研究慢性中性粒细胞白血病(CNL)伴单克隆免疫球蛋白增高这种罕见血液病。方法:报告1例CNL伴单克隆免疫球蛋白增高患者,并复习国内外相关文献。结果:患者中性粒细胞明显增多,脾大,中性粒细胞碱性磷酸酶积分增高,无Ph染色体及BCR/ABL融合基因,骨髓粒系增生,无病态造血和明显纤维化依据,排除了如类白血病反应、其他克隆性血液病引起的中性粒细胞增多,合并单克隆免疫球蛋白增高意义未明,目前已排除淋巴瘤,尚不能诊断为多发性骨髓瘤。结论:CNL是一种少见的骨髓增殖性疾病,CNL与单克隆免疫球蛋白增高的相关性和治疗方法需要进一步明确。 Aims: To investigate the association of chronic neutrophilic leukemia (CNL) with monoclonal immunoglobulin in this rare blood disease. Methods: One case of CNL with monoclonal immunoglobulin was reported, and the related literature at home and abroad was reviewed. Results: Patients with neutrophils increased significantly, spleen, neutrophil alkaline phosphatase score increased, no Ph chromosome and BCR / ABL fusion gene, bone marrow myeloid hyperplasia, no pathological hematopoiesis and obvious fibrosis basis, ruled out Such as leukemia reaction, other clonogenic hematopathy caused by neutrophils, combined with monoclonal immunoglobulin increased significance of unknown, lymphoma has been ruled out, yet to be diagnosed as multiple myeloma. CONCLUSION: CNL is a rare myeloproliferative disease. The correlation between CNL and monoclonal immunoglobulin and its treatment need to be further clarified.
其他文献
谷氨酰胺是体内含量最丰富的氨基酸,约占总游离氨基酸的50%,是合成氨基酸、蛋白质、核酸和许多其他生物分子的前体物质,在肝、肾、小肠和骨骼肌代谢中起重要的调节作用,是机
免疫检查点阻断(ICB)是激活抗肿瘤免疫的有效策略之一,在多种恶性肿瘤的治疗中取得了显著成效,具有广阔的应用前景.然而,临床治疗结果表明,仅有少数患者可以产生有效应答,而